The telehealth sector witnessed a transformative move on June 3, 2025, as Hims & Hers Health (NYSE: HIMS) announced its acquisition of ZAVA, a leading European digital health platform. This $1.2...
As Merck & Co. confronts the impending 2028 patent expiration of its $29.5 billion oncology blockbuster Keytruda, the pharmaceutical giant's reported $3 billion pursuit of MoonLake...
In a landmark move signaling deeper convergence between optical manufacturing and clinical care, EssilorLuxottica announced its acquisition of Optegra Eye Health Care from private equity firm...
McKesson Corporation solidified its position in community oncology with the June 2025 completion of its $2.49 billion acquisition of 70% controlling interest in Core Ventures, the administrative arm...
Bruker Corporation's $BRKR acquisition of Austrian metabolomics leader Biocrates Life Sciences AG marks a pivotal expansion in the $12.7 billion multiomics sector . This undisclosed-value...
Checkpoint Therapeutics' proposed acquisition by Sun Pharmaceutical Industries has encountered significant legal challenges as shareholders file suit in Delaware's Court of Chancery. The litigation...
The Federal Trade Commission's extended review of Alcon's proposed $430 million acquisition of Lensar Inc. highlights growing regulatory attention on medical technology consolidation. While the...
As global mining giants recalibrate portfolios amid shifting commodity demands, Dundee Precious Metals' (TSX:DPM) potential acquisition of Adriatic Metals (LSE:ADT1) emerges as a defining...
An Illinois appellate panel affirmed the dismissal of a shareholder class action against AbbVie Inc. on May 21, 2025, resolving allegations that the biopharmaceutical giant issued unregistered...
In a strategic move to strengthen its neurology pipeline, Sanofi announced on May 21, 2025, its definitive agreement to acquire Vigil Neuroscience for up to $600 million. The transaction centers on...
